In the stroke core, 1.3% of cells were double positive for HuNu and Olig2 in the NPCacute group, whereas only 0.5% were HuNu/Olig2‐positive in the NPCdelayed group (p = 0.057). This evidence concerns the gene OLIG2 and stroke disorder.